LP220644-1
Simeprevir
Active
Description
Simeprevir (formerly TMC435, tradenames Olysio and Sovriad) is a second generation, highly specific and potent direct antiviral agent (DAA) inhibitor of HCV NS3/4A protease, for the treatment of hepatitis C virus (HCV) infection. Simeprevir is indicated for treating chronic HCV infection as a part of a triple antiviral treatment regimen along with two other drugs, PEG-IFN and RBV. It is primary efficacious in treating HCV genotype 1 infected patients with compensated liver disease including cirrhosis. PMID: 26904396 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Simeprevir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-07-18
- Construct for LOINC Short Name
- Simeprevir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP220644-1
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 司美匹韦 Synonyms: Simeprevir; |
| es-ES | Spanish (Spain) | Simeprevir |
| it-IT | Italian (Italy) | Simeprevir |
| nl-NL | Dutch (Netherlands) | simeprevir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright